Nafamostat mesylate has advantages as an anticoagulant for patients undergoing maintenance hemodialysis with conjunctival bleeding.

Tang, Jian-Ying; Yang, Lu; Wang, Jing; Yang, Ying; Li, Jun-Chen; Mu, Jiao

Tang, Jian-Ying; Yang, Lu; Wang, Jing; Yang, Ying; Li, Jun-Chen; Mu, Jiao.

Afiliación

Tang JY; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Yang L; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Wang J; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Yang Y; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Li JC; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.
Mu J; Department of Nephrology, University-Town Hospital of Chongqing Medical University, Chongqing, China.

Clin Kidney J ; 17(7): sfae175, 2024 Jul.

Article en En | MEDLINE | ID: mdl-39021812

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Kidney J Año: 2024 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google